Coronary Artery Disease
Hair whitening score, hypertension, and dyslipidemia were all independent predictors of atherosclerotic coronary artery disease.
Heterozygous carriers of ANGPTL3 loss-of-function mutations demonstrated a 17% reduction in circulating triglycerides and a 12% reduction in low-density lipoprotein cholesterol.
Fasting pancreatic polypeptide may be a marker for macrovascular disease.
Elevated coronary artery disease risk is independent of type 2 diabetes and other CAD risk factors.
Revised coronary revascularization criteria rated whether coronary interventions are appropriate in tables organized according to practice patterns.
After 5 years, the cumulative incidence of MACE was 6.7% in the everolimus-eluting stent group and 11.2% in the sirolimus-eluting stent group.
Hormone replacement therapy in postmenopausal women was associated with lower coronary artery calcium scores as well as lower risk of long-term all-cause mortality.
Coronary computed tomographic angiography does not reduce cardiac events in patients with suspected coronary artery disease.
Patients with diabetes had more CV risk factors and higher rates of noninvasive testing positivity as well as 60-day aspirin, statin, ACE inhibitor, and ARB use.
The investigators suggested that more research is needed to truly understand the pathophysiology behind cannabis' effect.
Risk of cardiovascular disease gradually increased in patients undergoing darunavir therapy.
The HART test has been found to be more accurate than standard diagnostic methods in identifying coronary artery disease.
Rivaroxaban met its primary end point well ahead of the scheduled March 2018 trial conclusion.
RenalGuard therapy was linked to significantly reduced incidences of contrast-induced acute kidney injury.
The association between proton pump inhibitor use and incidence of heart failure and death was recently evaluated in a study.
Low hemoglobin levels independently predicted all-cause, cardiovascular, and noncardiovascular mortality in patients with coronary artery disease.
Renin-angiotensin system inhibitors reduced cardiovascular events in patients with coronary artery disease when compared with placebo but not active controls.
Coronary artery calcium was found in 10.2% of participants aged 18 to 30 years during year 15 of the study.
Three revascularization techniques were compared in patients with concomitant carotid and coronary artery disease undergoing CABG.
Postmenopausal women with paracardial adipose tissue may be at an increased risk of developing CVD.
Significantly decreased platelet reactivity occurred in patients who were given a new statin or an increased dose of a previous statin.
Higher SYNTAX scores may predict major cardiovascular events in patients with coronary artery disease and diabetes.
A prospective cohort study in 66 patients with end-stage renal disease was conducted to determine the link between renal and coronary heart diseases.
A review of cardiovascular disease burden, particularly coronary heart disease, in HIV/AIDS.
A large number of patients with psoriatic arthritis may have silent coronary artery disease.
A real-world study of fractional flow-reserve-guided revascularization in coronary artery disease identified several concerns with use of the technique.
While mortality rates were similar between percutaneous coronary intervention and coronary artery bypass grafting in both EXCEL and NOBLE trials, the risk of major cardiovascular events was higher in PCI in NOBLE.
Patients with coronary artery disease who also had depressive symptoms were more likely to report poor functional status.
Peri-operative complicatoions were limited by the use of tranexamic acid in coronary artery surgery.
Liraglutide increased heart rate and reduced heart rate variability in overweight patients with stable coronary artery disease and newly diagnosed type 2 diabetes.
The Cardiology Advisor Articles
- Measuring Visceral Adipose Tissue With DXA to Predict Atherosclerotic CVD
- Role of Race and Ethnicity in Cardiovascular Health
- Cardiopulmonary Exercise Test: A Beneficial Prognostic Test
- Is A Reduction in BP Likely Using Uric Acid-Lowering Agents?
- Are Patients Aware the Importance of Cholesterol Management?
- Should You Agree to Provide Preoperative Cardiology "Clearance"?
- GI Bleeding Risk in Non-Valvular AF Lower With Apixaban
- ACC Updated Criteria: Coronary Revascularization in Stable Ischemic Heart Disease
- Recurrent MI Risk, CHD Events Increased with Statin Intolerance
- Dissecting the Latest Trends and Controversies in Cardiovascular Nutrition